Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| BioAtla, Inc. | 52,307 | reported | 18 Jun 2025 | tx 5+122,307 |
| Tyra Biosciences, Inc. | 13,160 | reported | 28 May 2026 | tx 3+72,560 |
| GLYCOMIMETICS INC | 9,023 | reported | 23 Jun 2025 | tx 1+9,023 |
| RayzeBio, Inc. | 0 | reported | 26 Feb 2024 | tx 8+194,875−851,406 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 28 May 2026 | GRANT_AWARD | Tyra Biosciences, Inc. | 13,160 | 0.00 USD | deriv |
| 23 Jun 2025 | GRANT_AWARD | GLYCOMIMETICS INC | 9,023 | 0.00 USD | deriv |
| 18 Jun 2025 | GRANT_AWARD | BioAtla, Inc. | 23,500 | 0.00 USD | |
| 29 May 2025 | GRANT_AWARD | Tyra Biosciences, Inc. | 22,200 | 0.00 USD | deriv |
| 13 Jun 2024 | GRANT_AWARD | BioAtla, Inc. | 16,500 | 0.00 USD | |
| 07 May 2024 | GRANT_AWARD | Tyra Biosciences, Inc. | 37,200 | 0.00 USD | deriv |
| 26 Feb 2024 | OTHER | RayzeBio, Inc. | 323,455 | 62.50 USD | |
| 26 Feb 2024 | OTHER | RayzeBio, Inc. | 164,000 | — | deriv |
| 26 Feb 2024 | OTHER | RayzeBio, Inc. | 77,805 | — | deriv |
| 26 Feb 2024 | OTHER | RayzeBio, Inc. | 60,757 | — | deriv |
| 26 Feb 2024 | OTHER | RayzeBio, Inc. | 194,514 | — | deriv |
| 22 Jan 2024 | EXERCISE | RayzeBio, Inc. | 30,875 | 3.24 USD | |
| 22 Jan 2024 | EXERCISE | RayzeBio, Inc. | 30,875 | 0.00 USD | deriv |
| 17 Nov 2023 | GRANT_AWARD | RayzeBio, Inc. | 164,000 | 0.00 USD | deriv |
| 14 Jun 2023 | GRANT_AWARD | BioAtla, Inc. | 50,000 | 0.00 USD | deriv |
| 16 Jun 2022 | GRANT_AWARD | BioAtla, Inc. | 20,000 | 0.00 USD | deriv |
| 15 Jun 2021 | GRANT_AWARD | BioAtla, Inc. | 12,307 | 0.00 USD | deriv |